Literature DB >> 32584458

Brodalumab: another helpful option for HIV-positive psoriatic patients?

Vito Di Lernia1, Dahiana M Casanova1, Cinzia Ricci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32584458     DOI： 10.1111/dth.13895

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  TNF-alpha inhibitors and ustekinumab for the treatment of psoriasis: therapeutic utility in the era of IL-17 and IL-23 inhibitors.

Authors:  Julie J Hong; Edward K Hadeler; Megan L Mosca; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2022-01-12

2.  Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast.

Authors:  Paolo Romita; Caterina Foti; Gianluca Calianno; Andrea Chiricozzi
Journal:  Dermatol Ther       Date:  2022-06-07       Impact factor: 3.858
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.